Literature DB >> 2455849

Effect of beta-adrenergic blockade on plasma levels of atrial natriuretic peptide during exercise in humans.

R C Tsai1, T Yamaji, M Ishibashi, F Takaku, S T Hsu, C Y Lai, S J Yeh, J S Hung, D L Wu, Y S Lee.   

Abstract

Effect of beta-adrenergic blockade on plasma levels of atrial natriuretic peptide (ANP) during treadmill exercise was studied in 9 healthy volunteers. Plasma ANP levels increased during exercise. The mean plasma ANP concentration on 12-min exercise (32.5 +/- 3.7 pg/ml, mean +/- SEM) was significantly higher than the control (16.7 +/- 1.0 pg/ml). After exercise, the levels decreased and the mean plasma ANP concentrations in the recovery period were higher in subjects in the sitting position than in subjects who kept standing. Prior administration of a long-acting propranolol, 160 mg daily for 3 consecutive days, augmented ANP release during exercise. The mean plasma ANP concentrations on 9- and 12-min exercise (34.5 +/- 3.1 and 64.9 +/- 15.0 pg/ml, respectively) were significantly higher than those in the corresponding exercise stage without propranolol. Plasma ANP levels in the recovery period also increased after the administration of propranolol and the subjects in the sitting position again had higher plasma levels than those in the standing position. These results suggest that increased central blood volume during exercise elevates atrial pressure to stimulate ANP secretion, and that greater atrial distension and pressure due to reduced ventricular contractility by beta-adrenergic blockade facilitates ANP release to a greater extent.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2455849     DOI: 10.1097/00005344-198805000-00015

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  6 in total

1.  Beta-adrenoceptor blockade potentiates exercise-induced release of atrial natriuretic peptide.

Authors:  G Deray; I Berlin; G Maistre; F Martinez; S Legrand; A Carayon; A Prost; A Puech; F Masson; J C Legrand
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Atrial natriuretic peptide in plasma after prolonged physical strain, energy deficiency and sleep deprivation.

Authors:  P K Opstad; A H Haugen; O M Sejersted; R Bahr; K K Skrede
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1994

3.  Beta-adrenoceptor blockade potentiates acute exercise-induced release of atrial natriuretic peptide by increasing atrial diameter in normotensive healthy subjects.

Authors:  I Berlin; P Lechat; G Deray; C Landault; G Maistre; V Chermat; R Brouard; C Ressayre; A J Puech
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

4.  Plasma concentrations of atrial natriuretic peptide during physical exercise in patients with congestive heart failure.

Authors:  M Haass; R Dietz; J Purgaj; R E Lang; W Kübler
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

5.  Effect of beta-adrenoceptor blockade on atrial natriuretic peptide levels during exercise in angina pectoris.

Authors:  M Riley; J S Elborn; G Onuoha; C Erwin; C Shaw; M M Khan; C F Stanford; D P Nicholls
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

6.  Cicletanine does not affect plasma atrial natriuretic peptide concentration in healthy subjects.

Authors:  I Berlin; G Deray; G Maistre; F Masson; C Barthelemy; J C Legrand; C Jacobs
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.